DCZ19931
DCZ19931 is a potent multi-targeting kinase inhibitor. DCZ19931 has anti-angiogenic effects on ocular neovascularization. DCZ19931 also inhibits ERK1/2-MAPK and p38-MAPK signaling.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2789629-84-9
- Fòrmula: C26H20F5N3O5
- Peso molecular:549.45
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Actividad biológica
|
ERK1 |
ERK2 |
p38 MAPK |
DCZ19931 (1 nM-10 μM; 24 h) shows no obvious cytotoxicity against human umbilical vein endothelial cells (HUVECs)[1].
DCZ19931 (500 nM; 24 h) suppresses (10 ng/mL; 12 h) VEGF-induced proliferation, migration, and tube formation ability of endothelial cells[1].
DCZ19931 (500 nM; 24 h) inhibits vascular permeability via downregulation of ICAM-1 expression[1].
DCZ19931 (500 nM; 24 h) reduces the expression levels of p-ERK1/2, p-p38, and p-JNK in HUVECs[1].
DCZ19931 also shows anti-angiogenic effects in mouse choroidal sprouting assays[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Human umbilical vein endothelial cells (HUVECs)
-
Concentration:500 nM; with or without 50 ng/mL VEGF for 30 min
-
Incubation Time:24 hours
-
Result:Decreased expression of phosphorylated ERK and phosphorylated p38.
DCZ19931 (2 μL, 1 μg/μL; intravitreal injection; 7 d) has no tissue toxicity, and inhibits ocular neovascularization in mice with laser-induced choroidal neovascularization (CNV) model[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Laser-induced choroidal neovascularization (CNV) model in mice[1]
-
Dosage:2 μL, 1 μg/μL
-
Administration:Intravitreal injection; single dose, monitored for 7 d following laser photocoagulation
-
Result:Did not cause marked histopathological changes in retinal structures.
Decreased the areas of CNV lesions, showed anti-angiogenic effect in vivo.
-
Animal Model:Oxygen-induced retinopathy (OIR) model in mice[1]
-
Dosage:1 μL, 1 μg/μL
-
Administration:Intravitreal injection; single dose
-
Result:Further showed anti-angiogenic effect in vivo, inhibited ocular neovascularization.
Chemical Information
-
No. CAS 2789629-84-9
-
Peso molecular 549.45
-
Fòrmula C26H20F5N3O5
-
SMILES
COC1=CC(NC(C(F)(C2=CC=C(C=C2)OC3=C4C=C(C(OC)=CC4=NC=N3)OC)F)=O)=CC(C(F)(F)F)=C1
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
DCZ19931 Related Classifications
HY-152087 Related Classifications
Powered by Bioz